A bispecific antibody targeting the Ig domains of Siglec-E displays enhanced antitumor effects.
Zhao D, Liu M, Zeng W, Chen S, Bibi S, Wang M, Huang X, Zhu F, Zheng P, Gao Y, Wu Q, Zhang H, Cheng Q, Sun C, Bai L, Zhu Z, Li B, Wu S, Shang Y, Hasi C, Ma H, Zhou S, Jin T.
Zhao D, et al. Among authors: zhu f, zhu z.
Int J Biol Macromol. 2024 Nov;281(Pt 4):136635. doi: 10.1016/j.ijbiomac.2024.136635. Epub 2024 Oct 16.
Int J Biol Macromol. 2024.
PMID: 39419134